eccogene glp-1 Enters Exclusive License Agreement With AstraZeneca to Develop and Commercialize Small Molecule Receptor Agonist ECC5004 for Cardiometabolic Diseases AstraZeneca's oral GLP-1 scored phase
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3





























